EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Neutrophil-to-Lymphocyte ratio in moderate and severe COVID-19 among hospitalized adults: A retrospective study from a resource limited setting in Pakistan

Aijaz Zeeshan Khan Chachar, Komal Qazi, Atif Munir, Eshal Amir, Eesha Iqbal, Syed Adnan Hussain Shahid

Proceedings · 2026-10-18 · 40 (3) · 320-325

DOI: 10.47489/szmc.v40i3.955 ↗
AbstractBibliografische Angaben

Abstract

Background: Coronavirus disease 2019 (COVID-19) has a broad clinical spectrum. Simple and inexpensive inflammatory markers may help characterize patients with more severe illness in resource-limited settings. The neutrophil-to-lymphocyte ratio (NLR), derived from a routine complete blood count, has been associated with COVID-19 severity in previous studies. Methods: A retrospective study included 635 adults who were hospitalized with reverse-transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19 in Lahore, Pakistan. Demographic, clinical, and laboratory information was reviewed. NLR was calculated from complete blood count parameters and is reported as median (interquartile range [IQR]). Categorical associations with disease severity were assessed from the retained aggregate counts using Pearson's chi-square test for age categories and two-sided Fisher's exact test for 2 x 2 comparisons. Results: Severe disease was recorded in 490 (77.2%) patients and moderate disease in 145 (22.8%). Median NLR was 11.1 (IQR 12.7) in the severe group and 2.6 (IQR 2.4) in the moderate group. Sex was not associated with severity (two-sided Fisher's exact p=0.482). Obesity showed a borderline but non-significant association with severity (p=0.054). Overall, 200 (31.5%) patients died and 435 (68.5%) were discharged. Conclusion: NLR was markedly higher in the severe group than in the moderate group and may be a simple marker associated with disease severity in hospitalized patients. Because patient-level data were unavailable for receiver operating characteristic (ROC) analysis, effect-Zize estimation, and multivariable adjustment, these findings do not establish NLR as an independent predictor or define its clinical discriminatory performance.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →